Expert opinion on the clinical use and benefits of liposomal iron in the treatment of anemia in Indian settings

Manjula S.; Krishna Kumar M.

doi:10.18203/2320-6012.ijrms20240528

Authors

Manjula S. Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India
Krishna Kumar M. Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240528

Keywords:

Hemoglobin, Chronic kidney disease, Conventional iron, Liposomal iron, Anemia

Abstract

Background: Several studies have reported the effectiveness and safety of liposomal iron in increasing hemoglobin levels and correcting anemia. However, there was a dearth of information regarding the prescription pattern of physicians regarding its use and advantages in the actual practice. The present survey-based study aims at gathering clinicians' perspectives regarding the clinical use and benefits of liposomal iron in the treatment of anemia in Indian settings.

Methods: This cross-sectional study used a 19-item questionnaire to gather insights from specialists across different Indian settings regarding their perspectives on anemia and liposomal iron.

Results: Out of 124 participants, 77% opined that liposomal iron was highly bioavailable, achieves much higher plasma iron concentration, and bypasses the extremely restrictive, normal intestinal barriers. Oral liposomal iron was preferred by 77% of clinicians for the rapid increase in hemoglobin level and 99% of clinicians reported improved patient compliance with liposomal iron therapy for anemia. According to 50% of clinicians, oral liposomal iron was effective in non-hemodialysis dependent chronic kidney diseases and 87% of clinicians reported that patients without CKD needed oral liposomal iron. Half of the respondents reported a significant increase in Hb with liposomal iron in both dialysis and non-dialysis patients.

Conclusions: The survey participants reported that liposomal iron treatment for anemia was beneficial in treating both CKD and non-CKD patients. The survey findings have corroborated the advantages of liposomal iron for treating anemia such as increased bioavailability, rapid and effective increase in Hb level, better patient compliance and tolerability, decreased side effects, cost-effectiveness, and flexible dosing.

Metrics

Metrics Loading ...

References

GBD 2021 Anaemia Collaborators. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(9):e713-34.

Anaemia. Available at: https://www.who.int/news-room/fact-sheets/detail/anaemia. Accessed on 20 November 2023.

Anaemia mukt Bharat. Available at: https://pib.gov. in/pib.gov.in/Pressreleaseshare.aspx?PRID=1795421. Accessed on 20 November 2023.

Stevens GA, Paciorek CJ, Flores-Urrutia MC, Borghi E, Namaste S, Wirth JP, et al. National, regional, and global estimates of anaemia by severity in women and children for 2000-19: a pooled analysis of population-representative data. Lancet Global Health. 2022; 10(5):e627-39.

Malhotra J, Garg R, Malhotra N, Agrawal P. Oral liposomal iron: a treatment proposal for. World J Anemia. 2019;2:1-6.

Hanna RM, Streja E, Kalantar-Zadeh K. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther. 2021;38(1):52-75.

Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014; 9(1):e84943.

Zaawari A, Tejaswini KL, Davina GD, Singanaveni A. Prevalence of anemia among chronic kidney disease patients in India: a single-centre study. Int J Basic Clin Pharmacol. 2022;11(5):404-9.

Hussain S, Habib A, Najmi AK. Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional study. J Evid Based Med. 2019;12(4):243-52.

Gupta A, Kumar B, Kumar P, Gupta R. Prevalence of Chronic Kidney Disease and its Association with Risk Factors in Eastern Uttar Pradesh, India. J Clin Experi Nephrol. 2020;5(4):90.

Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a Novel Food Supplement (Ferfer®) containing microencapsulated iron in liposomal form in female iron deficiency anemia. Cureus. 2019;11(5): e4603.

Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dialy Transplant. 2015;30(4):645-52.

Flores PM. The safety and the effectiveness of the liposomal iron on the treatment for iron deficiency anemia in pediatric patients with chronic kidney disease in hemodialysis. Kidney Int Rep. 2022;7(2): S104.

Montagud-Marrahi E, Arrizabalaga P, Abellana R, Poch E. Liposomal iron in moderate chronic kidney disease. Nefrología. 2020;40(4):446-52.

Aftab N, Faraz S, Hazari K, Fahad A, AlSawalhee N, AlQedrah A, et al. Evaluation of the Impact of Iron Deficiency Anemia during Pregnancy on Hospital Admission and Utilization of Hospital Resources in Latifa Women and Children Hospital, Dubai, UAE. Dubai Med J. 2021;4(3):242-7.

Prestifilippo A, Mafodda A, Maisano R, Giuffrida D, Mare M, Azzarello D, et al. Safety and Efficacy of Oral Liposomal Iron Supplemented in Cancer Patients with Chemotherapy-Related Anemia Receiving Epoetin Alfa. Final Data. Ann Oncol. 2012;23:505.

Maladkar M, Sankar S, Yadav A. A Novel Approach for Iron Deficiency Anaemia with Liposomal Iron: Concept to Clinic. JBM. 2020;8(9):27-41.

de Alvarenga ACV, de Alvarenga NCR, Campanha da RRT, de Alvarenga AP, de Andrade CL, Martins GFL, et al. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life. Int J Clin Pharm. 2020;42(3):895-902.

Bhalla A, Kaushal S. Oral Liposomal Iron: A Promising New Strategy for Anemia Management in Clinical Practice. Biomed Sci Clin Res. 2023;2(2): 211-4.

Visciano B, Nazzaro P, Tarantino G, Taddei A, Del Rio A, Mozzillo GR, et al. Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease. G Ital Nefrol. 2013;30(5):30.

Biniwale P, Pal B, Sundari T, Mandrupkar G, Datar N, Khurana AS, et al. Liposomal Iron for Iron Deficiency Anemia in Women of Reproductive Age: Review of Current Evidence. J Obstet Gynecol. 2018; 8(11):993.

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D’Amato T. Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. Int Orthop. 2019;43(1):39-46.